Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
OPIANT PHARMACEUTICALS, INC. | Director | Common Stock | 0 | $20.00 | Mar 2, 2023 | Direct | |
OPIANT PHARMACEUTICALS, INC. | Director | Stock Option (right to buy) | 0 | $10.00 | Mar 2, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OPNT | OPIANT PHARMACEUTICALS, INC. | Mar 2, 2023 | 6 | -$248K | 4 | Mar 3, 2023 | Director |
OPNT | OPIANT PHARMACEUTICALS, INC. | Jun 14, 2022 | 1 | $0 | 4 | Jun 14, 2022 | Director |
OPNT | OPIANT PHARMACEUTICALS, INC. | Sep 21, 2021 | 7 | -$90 | 4 | Sep 23, 2021 | Director |
OPNT | OPIANT PHARMACEUTICALS, INC. | Sep 14, 2021 | 9 | -$181 | 4 | Sep 16, 2021 | Director |
OPNT | OPIANT PHARMACEUTICALS, INC. | Sep 7, 2021 | 3 | -$46 | 4 | Sep 9, 2021 | Director |
OPNT | OPIANT PHARMACEUTICALS, INC. | Aug 19, 2021 | 2 | -$16.2K | 4 | Aug 20, 2021 | Director |
OPNT | OPIANT PHARMACEUTICALS, INC. | Jun 15, 2021 | 2 | $0 | 4 | Jun 16, 2021 | Director |